Plain-English translation of NCT06457217 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying a special type of brain imaging called magnetic resonance spectroscopic imaging (MRSI) in patients who have had a mild stroke caused by a blocked blood vessel in the brain. Researchers want to understand what happens in the brain during the first few days after a stroke and whether this imaging can predict which patients will get worse and need emergency treatment.
About half of all strokes are mild, but surprisingly, about 28% of patients with mild strokes cannot go home and 28% cannot walk independently. Even more concerning, some patients with mild symptoms suddenly get much worse. Doctors need a better way to identify which patients are at high risk for worsening so they can give them life-saving treatment right away.
You likely qualify if…
You likely don't qualify if…
You will receive brain imaging scans called MRSI at three time points: within the first 24 hours after your stroke, again at 5–7 days, and once more at 90 days. Each scan takes about 18–19 minutes. The study will track changes in your brain chemistry over time to see if the imaging can predict who might get worse. You'll need to be willing to comply with all study visits and procedures over the three-month period.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China